Results 241 to 250 of about 3,394,907 (379)

C-reactive protein- (CRP) mediated modulation of human B cell colony development. [PDF]

open access: bronze, 1983
Ronald L. Whisler   +2 more
openalex   +1 more source

β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1

open access: yesMolecular Oncology, EarlyView.
Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero   +8 more
wiley   +1 more source

The amino acid sequence of Limulus C-reactive protein. Evidence of polymorphism.

open access: hybrid, 1986
Nga Y. Nguyen   +3 more
openalex   +1 more source

Evaluation of a particle-enhanced immunoassay for quantifying C-reactive protein. [PDF]

open access: bronze, 1989
Thomas B. Ledue   +3 more
openalex   +1 more source

Unveiling unique protein and phosphorylation signatures in lung adenocarcinomas with and without ALK, EGFR, and KRAS genetic alterations

open access: yesMolecular Oncology, EarlyView.
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi   +12 more
wiley   +1 more source

Editorial: Biology of C-reactive protein

open access: yesFrontiers in Immunology
Alok Agrawal, Yi Wu
doaj   +1 more source

Effect of C‐Reactive Protein on Peritoneal Macrophages [PDF]

open access: bronze, 1988
N Miyagawa   +2 more
openalex   +1 more source

Olaparib synergy screen reveals Exemestane induces replication stress in triple‐negative breast cancer

open access: yesMolecular Oncology, EarlyView.
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh   +5 more
wiley   +1 more source

The Association Between S100A12 Protein and C-Reactive Protein with Malignant Ventricular Arrhythmias Following Acute Myocardial Infarction in the Elderly

open access: yesJournal of Inflammation Research
Lei Song, Ying-Min Lu, Jin-Chun Zhang, Yu-Min Yuan, Gui-Ru Li Department of Cardiology, Chongming Hospital Affiliated to Shanghai University of Medicine and Health Sciences, Shanghai, 202150, People’s Republic of ChinaCorrespondence: Ying-Min Lu ...
Song L, Lu YM, Zhang JC, Yuan YM, Li GR
doaj  

Home - About - Disclaimer - Privacy